Confusion Over COVID Vaccine Safety Led to Many Avoidable Stillbirths

This story was originally published by ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox. Late one afternoon last October, Dr. Shelley Odronic sat in her office and, just as she had thousands of times before, slid a rectangular glass slide onto her microscope. A pathologist who works in rural Ohio, Odronic leaned forward to examine tissue from the placenta of a woman who had recently given birth. She increased the magnification on the microscope. Never had she seen so many tiny, congealed reservoirs of…

NDN Changemaker Showcase Features 14 Indigenous Leaders from Across Turtle Island, Puerto Rico, and the Pacific Islands

The two-day event featured NDN Changemaker Fellows who are radically transforming Indigenous communities by defending Indigenous lands and rights, developing sustainable solutions for the future, and decolonizing their day-to-day lives, their families, communities and Nations.

CBO: Letting Medicare Negotiate Drug Prices Would Save US Nearly $290 Billion

The Congressional Budget Office said Friday that a pending proposal by Senate Democrats to allow Medicare to negotiate directly with drug companies for lower prices would yield nearly $290 billion in savings and new revenue over ten years of implementation, a predictable yet crucial finding as lawmakers try to revitalize a legislative deal in the coming weeks. The Democratic effort to revitalize a broader reconciliation package that could be passed in the narrowly-split Senate without Republican votes is considered the best that can be achieved after Sens. Joe Manchin and Kyrsten Sinema tanked the much larger Build Back Better plan…

Activists Say WTO Deal on Vaccine Patents Is “Sham” Dictated by Rich Nations

The World Trade Organization’s 12th Ministerial Conference ended Friday with an agreement on patent rights that campaigners said would do virtually nothing to address vast global inequities in coronavirus vaccine and treatment access, a failure they attributed to relentless obstruction by rich countries and the pharmaceutical industry. Reached after marathon negotiations, the narrow deal clarifies governments’ ability to use compulsory licensing to ramp up vaccine production without the consent of patent-holding pharmaceutical companies. The agreement also temporarily eases restrictions on the export of vaccines produced under compulsory licenses. The final text, which is set to remain in effect for a…

Progressive Jamie McLeod-Skinner Triumphs Over Big Pharma Ally Kurt Schrader

Progressive candidate Jamie McLeod-Skinner has won the Democratic primary in Oregon’s fifth district, ousting conservative Democrat Rep. Kurt Schrader, who worked with fellow conservatives in the party to undermine Democrats’ agenda last year. With over 80 percent of votes counted, numerous outlets, including The Associated Press, have called the race for McLeod-Skinner, making her the Democratic House candidate in the blue-leaning district that includes southern Portland suburbs and Salem. With about 57 percent of the vote, the progressive won by a nearly 15-point margin over Schrader, who she’s previously dubbed as the “[Sen.] Joe Manchin of the House.” “Our battle…

Jamie McLeod-Skinner Is on the Verge of Ousting Blue Dog Kurt Schrader in Oregon

Blue Dog conservative Democrat Rep. Kurt Schrader appears to be on the verge of losing his primary in Oregon to progressive challenger Jamie McLeod-Skinner after spending much of the last year voting to block much of his party’s agenda. With about 77 percent of votes counted in Oregon’s fifth district, McLeod-Skinner has 59.3 percent of the votes, according to tallies available at the time of this reporting. Schrader is trailing behind by nearly 19 points, with 40.7 percent. The race was called for McLeod-Skinner by Cook Political’s House editor Dave Wasserman on Twitter on Tuesday morning, but has yet to…

First Quarter of 2022 Sees Record $1 Billion Spent on Lobbying

This year is on track for record lobbying spending after lobbyists collectively clocked the biggest first quarter haul in history — with more than $1 billion disclosed during the first quarter of 2022 alone. At this point in 2021, 10,503 lobbyists had brought in less than $929 million across all industries. The federal budget was the most lobbied issue from January through March, with 3,394 clients paying for lobbying on the issue. Health issues were also heavily lobbied, with 2,068 clients. Lobbying related to health continues to dominate spending as recovery from the coronavirus pandemic continues. The health sector accounted…

Translate »